Nama Insights

F/m Emerald Life Sciences Innovation ETF (LFSC)

Health · Emerald Mutual Fund Advisers Trust · NASDAQ

HealthETF
F/m Emerald Life Sciences Innovation ETF (LFSC) is an exchange-traded fund in the Health category. It has $126.27M in assets, an expense ratio of 0.54% and a 0.00% dividend yield. The fund is an actively managed exchange-traded fund (“ETF”) and invests primarily in equity securities of life science companies selected by Emerald Mutual Fund Advisers Trust, the fund’s investment sub-adviser, under the supervision of the adviser. Under normal market conditions, the fund invests at least 80% of its net assets in equity securities issued by life science companies demonstrating innovation.
Assets under management$126.27M
Expense ratio0.54%
CategoryHealth
Dividend yield0.00%
NAV$45.14
Fund familyEmerald Mutual Fund Advisers Trust
ExchangeNASDAQ

Top holdings

The largest positions F/m Emerald Life Sciences Innovation ETF reports, by weight.

HoldingNameWeight
TVTX Travere Therapeutics Inc Ordinary Shares 8.71%
CORT Corcept Therapeutics Inc 6.72%
SYRE Spyre Therapeutics Inc 6.70%
LIVN LivaNova PLC 6.61%
COGT Cogent Biosciences Inc 6.48%
MIRM Mirum Pharmaceuticals Inc 4.32%
BLLN BillionToOne Inc Ordinary Shares - Class A 3.86%
GH Guardant Health Inc 3.81%
CYTK Cytokinetics Inc 3.50%
UTHR United Therapeutics Corp 3.27%

Other Health ETFs

Explore live LFSC data on Nama Insights →